# Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects

> **NCT06481709** · PHASE1 · COMPLETED · sponsor: **APR Applied Pharma Research s.a.** · enrollment: 16 (actual)

## Conditions studied

- Bioavailability

## Interventions

- **DRUG:** RLF-OD032
- **DRUG:** Kuvan

## Key facts

- **NCT ID:** NCT06481709
- **Lead sponsor:** APR Applied Pharma Research s.a.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-30
- **Primary completion:** 2024-08-31
- **Final completion:** 2024-08-31
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06481709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06481709, "Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT06481709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*